[1] Chen X, Ren Z, Li C, et al. Preclinical study of locoregional therapy of hepatocellular carcinoma by bioelectric ablation with microsecond pulsed electric fields (μsPEFs)[J]. Sci Rep, 2015, 5: 9851.
[2] Figueras J, Jaurrieta E, Valls C, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy[J]. J Am Coll Surg, 2000, 190: 580- 587.
[3] Bruix J, Sherman M. Management of hepatocellular carcinoma[J]. Hepatology, 2005, 42: 1208- 1236.
[4] Cho YK, Kim JK, Kim MY, et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies[J]. Hepatology, 2009, 49: 453- 459.
[5] Golberg A, Bruinsma BG, Uygun BE, et al. Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by“electric field sinks”[J]. Sci Rep, 2015, 5: 8485.
[6] 李成祥, 孙才新, 姚陈果, 等. 不可逆电穿孔治疗技术的临床前大动物实验研究[J]. 高电压技术, 2010, 36: 1253- 1257.
[7] 梁 冰, 牛立志, 曾健滢, 等. 不可逆电穿孔消融兔胆囊侧肝脏病理学观察[J]. 介入放射学杂志, 2014, 23: 320- 324.
[8] 孙 钢. 不可逆电穿孔技术消融肿瘤研究进展[J]. 介入放射学杂志, 2015, 24: 277- 281.
[9] Ricke J, Jurgens JH, Deschamps F, et al. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase Ⅱ trial on lung malignancies: the ALICE trial[J]. Cardiovasc Intervent Radiol, 2015, 38: 401- 408.
[10] 黎 升, 曾 奇, 钟 锐, 等. 不可逆电穿孔与射频消融后猪肝脏再生的比较[J]. 中华医学杂志, 2015, 95: 66- 68.